Filing Flows › Syra Health (SYRA) › Q2 2026 › vs Q2 2025
Syra Health (SYRA) Q2 2026 vs Q2 2025 (year over year)
Syra Health's revenue rose $448K (+23%) from $1.9M in Q2 2025 to $2.4M in Q2 2026. The biggest changes: Healthcare Workforce +$316K (+87%); Population Health +$133K (+8%). Gross margin 44.5% against 38.7% (+5.8 pts).
Syra Health, Q2 2026: revenue $2.4M (+23% year over year), operating margin 10.5%, net earnings $250K, operating cash flow −$719K. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 44.5% | 38.7% | +5.8 pts |
| Operating margin | 10.5% | -3.2% | +13.8 pts |
| Net margin | 10.5% | -3.3% | +13.7 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Population Health | $1.7M | $1.6M | $133K | +8% |
| Healthcare Workforce | $678K | $362K | $316K | +87% |
| Revenue | $2.4M | $1.9M | $448K | +23% |
| Gross profit | $1.1M | $753K | $313K | +42% |
| Cost of revenue | $1.3M | $1.2M | $135K | +11% |
| Operating profit | $252K | −$63K | $315K | — |
| Operating expenses | $815K | $816K | −$1K | -0.2% |
| Pre-tax earnings | $250K | −$64K | $314K | — |
| Research & development | $47K | $30K | $18K | +59% |
| SG&A | $236K | $289K | −$53K | -18% |
| Other operating costs | $531K | $497K | $34K | +7% |
| Net earnings | $250K | −$64K | $314K | — |
| Operating cash sources | $991K | $36K | $955K | 28× |
| Depreciation | $1K | $6K | −$5K | -88% |
| Share-based compensation | $21K | $21K | −$28 | -0.1% |
| Cash used in operations | $719K | $72K | $646K | +892% |
| Working capital & other | $991K | $36K | $955K | 28× |
Questions
How much did Syra Health's revenue grow year over year in Q2 2026?
Syra Health's revenue rose $448K (+23%) from $1.9M in Q2 2025 to $2.4M in Q2 2026.
What drove Syra Health's revenue change in Q2 2026?
Healthcare Workforce +$316K (+87%); Population Health +$133K (+8%).